Passive (amyloid-β) immunotherapy attenuates monoaminergic axonal degeneration in the AβPPswe/PS1dE9 mice.
about
Inflammatory process in Alzheimer's DiseaseAxonal degeneration as a therapeutic target in the CNS.The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease.Space Balls Revisited: Stereological Estimates of Length With Virtual Isotropic Surface Probes.
P2860
Passive (amyloid-β) immunotherapy attenuates monoaminergic axonal degeneration in the AβPPswe/PS1dE9 mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Passive (amyloid-β) immunother ...... on in the AβPPswe/PS1dE9 mice.
@ast
Passive (amyloid-β) immunother ...... on in the AβPPswe/PS1dE9 mice.
@en
Passive
@nl
type
label
Passive (amyloid-β) immunother ...... on in the AβPPswe/PS1dE9 mice.
@ast
Passive (amyloid-β) immunother ...... on in the AβPPswe/PS1dE9 mice.
@en
Passive
@nl
prefLabel
Passive (amyloid-β) immunother ...... on in the AβPPswe/PS1dE9 mice.
@ast
Passive (amyloid-β) immunother ...... on in the AβPPswe/PS1dE9 mice.
@en
Passive
@nl
P2093
P2860
P356
P1476
Passive (amyloid-β) immunother ...... on in the AβPPswe/PS1dE9 mice.
@en
P2093
David R Borchelt
Donald L Price
Esther S Oh
Juan C Troncoso
Maria M James
P2860
P304
P356
10.3233/JAD-2010-101602
P577
2011-01-01T00:00:00Z